Do popular Weight-Loss drugs make surgery riskier? new study checks stomachs
NCT ID NCT06003985
Summary
This study used a bedside ultrasound to look at patients' stomachs right before surgery. Researchers wanted to see if people taking popular weekly GLP-1 weight-loss or diabetes drugs (like Ozempic or Mounjaro) were more likely to have food or liquid still in their stomachs, even after following standard pre-surgery fasting rules. This is important because having a full stomach during anesthesia can increase the risk of vomiting and serious lung complications. The study compared 354 patients taking these drugs to patients who were not.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POINT OF CARE ULTRASOUND are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Albany Medical Center
Albany, New York, 12208, United States
-
George Washington University Hospital
Washington D.C., District of Columbia, 20037, United States
-
Hospital for Special Surgery
New York, New York, 10021, United States
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
University Health Network
Toronto, Ontario, M5G 2C4, Canada
-
University of Virginia
Charlottesville, Virginia, 22903, United States
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.